Cardiovascular Pathology
Volume 19, Issue 2 , Pages 83-93 , March 2010

In vivo characterization of cytokine profiles and viral load during murine cytomegalovirus-induced acute myocarditis

  • Jethro Trees Ritter

      Affiliations

    • Department of Internal Medicine, University of California, Davis Health System, Sacramento, CA, USA
    • ,
  • Yajarayma J. Tang-Feldman

      Affiliations

    • Department of Internal Medicine, University of California, Davis Health System, Sacramento, CA, USA
    • Corresponding Author InformationCorresponding author. University of California, Davis Health System, 4610 X Street, Suite 3101, Sacramento, CA 95817, USA. Tel.: +1 530 754 6650; fax: +1 530 754 6652.
    • ,
  • G. Raymond Lochhead

      Affiliations

    • Department of Internal Medicine, University of California, Davis Health System, Sacramento, CA, USA
    • ,
  • Marko Estrada

      Affiliations

    • School of Veterinary Medicine, University of California, Davis, Davis, CA, USA
    • ,
  • Stephanie Lochhead

      Affiliations

    • Department of Internal Medicine, University of California, Davis Health System, Sacramento, CA, USA
    • ,
  • Cindy Yu

      Affiliations

    • Department of Pathology, University of California, Davis Health System, Sacramento, CA, USA
    • ,
  • Amanda Ashton-Sager

      Affiliations

    • Department of Pathology, University of California, Davis Health System, Sacramento, CA, USA
    • ,
  • Dipika Tuteja

      Affiliations

    • Department of Internal Medicine, University of California, Davis Health System, Sacramento, CA, USA
    • ,
  • Christian Leutenegger

      Affiliations

    • School of Veterinary Medicine, University of California, Davis, Davis, CA, USA
    • ,
  • Claire Pomeroy

      Affiliations

    • Department of Internal Medicine, University of California, Davis Health System, Sacramento, CA, USA
    • Corresponding Author InformationCorresponding author. University of California, Davis Health System, 4610 X Street, Suite 3101, Sacramento, CA 95817, USA. Tel.: +1 530 754 6650; fax: +1 530 754 6652.

Received 15 January 2008 ,Revised 17 June 2008 ,Accepted 3 December 2008.

References 

  1. See DM, Tilles JG. Viral myocarditis. Rev Infect Dis. 1991;13:951–956
  2. Kearney MT, Cotton JM, Richardson PJ, Shah AM. Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management. Postgrad Med J. 2001;77:4–10
  3. McManus BM, Chow LH, Wilson JE, Anderson DR, Gulizia JM, Gauntt CJ, et al. Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol. 1993;68:159–169
  4. Lenzo CL, Fairweather D, Shellam GR, Lawson CM. Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor. Immunology. 2001;213:52–61
  5. Lenzo CL, Fairweather D, Cull V, Shellam GR, James (Lawson) CM. Characterization of murine cytomegalovirus myocarditis: cellular infiltration of the heart and viral persistence. Mol Cell Cardiol. 2002;34:629–640
  6. Lenzo CL, Mansfield JP, Sivamoorthy S, Cull VS, James CM. Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-α therapy. Cell Immunol. 2003;223:77–86
  7. Lawson CM, O'Donoghue HL, Reed WD. Mouse cytomegalovirus infection induces antibodies which cross-react with the virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis. Immunol. 1992;75:513–519
  8. Wada H, Saito K, Kanda T, Kobayashi I, Fujii H, Fujigaki S, et al. Tumor necrosis factor-α (TNF-α) plays a protective role in acute viral myocarditis in mice- a study using mice lacking TNF-α receptor. Circulation. 2001;103:743–749
  9. Cull VS, Barlett EJ, James CM. Type I interferon gene therapy protects against cytomegalovirus induced myocarditis. Immunology. 2002;106:428–437
  10. Pomeroy C, Hilleren PJ, Jordan MC. Latent murine cytomegalovirus DNA in splenic stromal cells of mice. J Virol. 1991;65:3330–3334
  11. Tang-Feldman YJ, Wojtowicz A, Lochhead GR, Hale MA, Li Y, Pomeroy C. Use of quantitative real-time PCR (qRT-PCR) to measure cytokine transcription and viral load in murine cytomegalovirus infection. J Virol Methods. 2006;131:122–129
  12. Henry SC, Schmader K, Brown TT, Miller SE, Howell DN, Daley GG, et al. Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection. J Virol Methods. 2000;89:61–73
  13. Kipar A, Leutenegger CM, Hetzel U, Akens MK, Mislin CN, Reinacher M, et al. Cytokine mRNA levels in isolated feline monocytes. Vet Immunol Immunopathol. 2001;78:305–315
  14. SAS Institute, Inc . SAS® Version 9.1. Cary (NC): SAS Institute, Inc; 2002-2003;
  15. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death—learning from the past for the future. Circulation. 1999;99:1091–1100
  16. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994;72:561–566
  17. Mason J. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res. 2003;60:5–10
  18. Goldfeld AE, Maniatis T. Coordinate viral induction of tumor necrosis factor and interferon in human B cells and monocytes. Proc Natl Acad Sci U S A. 1989;86:1490–1494
  19. Yamada T, Matsumori A, Sasayama S. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation. 1994;89:846–851
  20. Matsumori A, Tomioka N, Kawai C. Protective effect of recombinant alpha-interferon on coxsackievirus B3 myocarditis in mice. Heart J. 1988;115:1229–1232
  21. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR. Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10 A mice. J Exp Med. 1992;175:1123–1129
  22. Saraste A, Arola A, Vuorinen T, Kyto V, et al. Cardiomyocyte apoptosis in experimental coxsakievirus B3 myocarditis. Cardiovasc Pathol. 2003;12:255–262
  23. Leung WCT, Hata J, Hashimoto K. Murine cytomegalovirus infection model in BALB/c mice-2. Pericarditis with myocardial involvement. Tokai J Exp Clin Med. 1986;11:303–311
  24. Gang DL, Barrett LV, Wilson EJ, Rubin RH, Medearis DN. Myopericarditis and enhanced dystrophic cardiac calcification in murine cytomegalovirus infection. Am J Pathol. 1986;124:207–215
  25. Oka K, Oohira K, Yatabe Y, Tanaka T, Kurano K, et al. Fulminant myocardits demonstrating uncommon morphology— a report of two autopsy cases. Virchows Arch. 2005;446:259–264
  26. Funseth E, Lindh U, Wesslen L, Friman G, Ilback NG. Trace element changes in the myocardium during coxsackievirus B3 myocarditis in the mouse. Biol Trace Elem Res. 2000;76:149–160
  27. Sole MJ, Liu P. Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated myocarditis. J Am Coll Cardiol. 1993;22(Suppl A):99A–105A
  28. Huber SA, Lodge PA. Coxsackievirus B-3 myocarditis in Balb/c mice: evidence for autoimmunity to myocyte antigens. Am J Pathol. 1984;116:21–29
  29. Kishomoto C, Kuribayashi K, Masuda T, Tomioka N, Hawai C. Immunological behavior of lymphocytes in experimental viral myocarditis: significance of T-lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c un/un mice. Circulation. 1985;71:1247–1254

 This work was supported by intramural research funds.

PII: S1054-8807(08)00182-8

doi: 10.1016/j.carpath.2008.12.001

Cardiovascular Pathology
Volume 19, Issue 2 , Pages 83-93 , March 2010

Article Tools

* Image Usage & Resolution